The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors
Open accessAbstract
OBJECTIVE: A1C is an optional method for diagnosing diabetes and also for detecting individuals at increased risk of the disease. However, how A1C compares with fasting (FPG) and 2-h plasma glucose for detecting at-risk individuals is not well known. RESEARCH DESIGN AND METHODS: A 2-h glucose tolerance test, frequently sampled intravenous glucose tolerance test, and A1C were obtained at the follow-up examination in 855 participants in the Insulin Resistance Atherosclerosis Study (IRAS). For this report, 385 individuals were at increased risk of diabetes as defined by A1C between 5.7 and 6.4%, impaired glucose tolerance (IGT), and/or impaired fasting glucose (IFG). RESULTS: IFG and IGT identified 69.1 and 59.5% of all individuals at increased risk of diabetes, respectively. A1C 5.7–6.4% detected 23.6% of all at-risk individuals, although more African Americans (31.4%) and Hispanics (35.2%) than non-Hispanic whites (9.9%). Relative to A1C, FPG was more strongly related to fasting insulin (r = 0.38 vs. 0.26; P < 0.01), acute insulin response (r = – 0.20 vs. – 0.09; P < 0.01), and waist circumference (r = 0.43 vs. 0.25; P < 0.001) by the Spearman correlation test. Similarly, 2-h plasma glucose was more strongly related to Si (r = – 0.40 vs. – 0.27; P < 0.01) and triglycerides (r = 0.30 vs. 0.08; P < 0.001). CONCLUSIONS: A1C 5.7–6.4% is less sensitive for detecting at-risk individuals than IFG and IGT, particularly among non-Hispanic whites. Single determinations of FPG and 2-h plasma glucose seem to be more precise correlates of insulin resistance and secretion than A1C and, in general, better for other metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Self-citationCowie, C. C., Rust, K. F., Byrd-Holt, D. D., Gregg, E. W., Ford, E. S., Geiss, L. S., Bainbridge, K. E., & Fradkin, J. E. (2010) · Diabetes Care · doi:10.2337/dc09-1524 · Cited by 689
Herman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Self-citationHemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women
Pradhan, A. D., Rifai, N., Buring, J. E., & Ridker, P. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.03.022 · Cited by 189
Park, S., Barrett-Connor, E., Wingard, D. L., Shan, J., & Edelstein, S. (1996) · Diabetes Care · doi:10.2337/diacare.19.5.450 · Cited by 161
Use of HbA1c in Predicting Progression to Diabetes in French Men and Women
Droumaguet, C., Balkau, B., Simon, D., Caces, E., Tichet, J., Charles, M. A., Eschwege, E., & the DESIR Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2525 · Cited by 159
A1C and Diabetes Diagnosis: The Rancho Bernardo Study
Kramer, C. K., Araneta, M. R. G., & Barrett-Connor, E. (2010) · Diabetes Care · doi:10.2337/dc09-1366 · Cited by 157
Zhou, X., Pang, Z., Gao, W., Wang, S., Zhang, L., Ning, F., & Qiao, Q. (2010) · Diabetes Care · doi:10.2337/dc09-1410 · Cited by 146
Cited by
Diagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
King, W. C., Hinerman, A. S., Belle, S. H., Wahed, A. S., & Courcoulas, A. P. (2018) · JAMA · doi:10.1001/jama.2018.14433 · Cited by 414
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
The Pros and Cons of Diagnosing Diabetes With A1C
Bonora, E., & Tuomilehto, J. (2011) · Diabetes Care · doi:10.2337/dc11-s216 · Cited by 379
Barry, E., Roberts, S., Oke, J., Vijayaraghavan, S., Normansell, R., & Greenhalgh, T. (2017) · BMJ · doi:10.1136/bmj.i6538 · Cited by 330
Metadata
- Authors
- Lorenzo, C., Wagenknecht, L. E., Hanley, A. J. G., Rewers, M. J., Karter, A. J., & Haffner, S. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-06-23
- Volume
- 33
- Issue
- 9
- Pages
- 2104-2109
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2116705629
- Cited by
- 176
- References
- 12
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors. https://app.cochat.ai/papers/10.2337/dc10-0679
- The paper
- Lorenzo, C., Wagenknecht, L. E., Hanley, A. J. G., Rewers, M. J., Karter, A. J., & Haffner, S. M. (2010). A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors. Diabetes Care. https://doi.org/10.2337/dc10-0679
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.